Holen Sie sich die Stockscreener-App
13.02
5.51%
0.68
Schlusskurs vom Vortag:
$12.34
Offen:
$12.4
24-Stunden-Volumen:
13.36M
Relative Volume:
1.07
Marktkapitalisierung:
$8.87B
Einnahmen:
$6.82B
Nettoeinkommen (Verlust:
$309.60M
KGV:
28.93
EPS:
0.45
Netto-Cashflow:
$747.20M
1W Leistung:
+1.56%
1M Leistung:
-4.05%
6M Leistung:
-41.09%
1J Leistung:
-38.26%
1-Tages-Spanne:
$12.39
$13.11
1-Wochen-Bereich:
$12.19
$13.59
52-Wochen-Spanne:
$11.82
$28.00
Avantor Inc Stock (AVTR) Company Profile
Firmenname
Avantor Inc
Sektor
Telefon
(610) 386-1700
Adresse
RADNOR CORPORATE CENTER, BUILDING ONE, RADNOR, PA
Vergleichen Sie AVTR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AVTR
Avantor Inc
|
13.02 | 8.74B | 6.82B | 309.60M | 747.20M | 0.45 |
|
ISRG
Intuitive Surgical Inc
|
511.00 | 183.59B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
181.28 | 51.10B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
88.66 | 42.51B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
267.40 | 36.95B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
218.90 | 15.88B | 2.90B | 467.20M | 306.90M | 6.37 |
Avantor Inc Stock (AVTR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-29 | Herabstufung | Goldman | Buy → Neutral |
| 2025-04-28 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-04-28 | Herabstufung | Stifel | Buy → Hold |
| 2025-04-28 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-01-17 | Herabstufung | UBS | Buy → Neutral |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-07-10 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-01-04 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-12-11 | Hochstufung | TD Cowen | Market Perform → Outperform |
| 2023-09-28 | Eingeleitet | Bernstein | Mkt Perform |
| 2023-07-31 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2023-07-31 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2023-06-21 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Hold |
| 2022-10-05 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-09-14 | Herabstufung | Cowen | Outperform → Market Perform |
| 2022-09-09 | Herabstufung | Cleveland Research | Buy → Neutral |
| 2022-08-25 | Eingeleitet | Credit Suisse | Neutral |
| 2022-04-04 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-08-30 | Fortgesetzt | Raymond James | Outperform |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-08-02 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-06-04 | Eingeleitet | Goldman | Buy |
| 2021-04-29 | Hochstufung | Stifel | Hold → Buy |
| 2021-03-03 | Eingeleitet | Barclays | Overweight |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-09-14 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-07-15 | Hochstufung | Cleveland Research | Neutral → Buy |
| 2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-11-15 | Eingeleitet | Stifel | Hold |
| 2019-08-02 | Eingeleitet | Cleveland Research | Neutral |
| 2019-06-14 | Eingeleitet | Janney | Buy |
| 2019-06-12 | Eingeleitet | Raymond James | Outperform |
| 2019-06-11 | Eingeleitet | Goldman | Buy |
| 2019-06-11 | Eingeleitet | Guggenheim | Buy |
| 2019-06-11 | Eingeleitet | JP Morgan | Overweight |
| 2019-06-11 | Eingeleitet | Jefferies | Buy |
| 2019-06-11 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2019-06-11 | Eingeleitet | Piper Jaffray | Neutral |
| 2019-06-11 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2019-06-11 | Eingeleitet | Robert W. Baird | Outperform |
| 2019-06-11 | Eingeleitet | SunTrust | Buy |
| 2019-06-11 | Eingeleitet | UBS | Buy |
| 2019-06-11 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Avantor Inc Aktie (AVTR) Neueste Nachrichten
Avantor Inc. Stock Analysis and ForecastOutstanding capital appreciation - Autocar Professional
What analysts say about Avantor Inc. stockFree Predictions - jammulinksnews.com
Analysts Offer Insights on Materials Companies: Avantor (AVTR) and Linde (LIN) - The Globe and Mail
Is Avantor Inc. a good long term investmentFree Trend-Following Techniques - jammulinksnews.com
Avantor appoints Emmanuel Ligner president and CEO - MSN
Avantor Announces Emmanuel Ligner as Next President and CEO - BioSpace
Avantor and Globus Medical appoint new CEOs - The Business Journals
Why Avantor (AVTR) Shares Are Trading Lower Today - TradingView
Avantor's Strategic Reinvigoration: How Emmanuel Ligner's Expertise Positions the Company for Outperformance in Life Sciences - AInvest
Wolfe Research maintains Peerperform rating on Avantor stock amid CEO transition - Investing.com Australia
Avantor Hires Emmanuel Ligner as Its New President, CEO - Medical Product Outsourcing
Avantor appoints Emmanuel Ligner president and CEO (AVTR:NYSE) - Seeking Alpha
Avantor names Emmanuel Ligner as new president and CEO - Investing.com Australia
Former Cytiva CEO Emmanuel Ligner Takes Helm at Avantor: 30-Year Industry Veteran to Drive Growth - Stock Titan
What drives Avantor Inc. stock priceMarket-beating performance - jammulinksnews.com
Bank of America Securities Sticks to Their Buy Rating for Avantor (AVTR) - The Globe and Mail
Avantor Stock Faces Significant Decline Amid Revenue ConcernsNews and Statistics - IndexBox
3 Reasons to Sell AVTR and 1 Stock to Buy Instead - Yahoo Finance
Earnings are growing at Avantor (NYSE:AVTR) but shareholders still don't like its prospects - simplywall.st
Avantor (AVTR) Q1 2025 Results Reflects Focus on Cost Management - MSN
11 Best Mid-cap Healthcare Stocks to Buy According to Hedge Funds - Insider Monkey
Tungsten Foil Market Report 2025-2030 | Competitive Analysis of Admat, American Elements, ATI, Avantor, Chemazone, Edgetech Industries, Goodfellow, Otto Chemie, Plansee, Techinstro, and More - GlobeNewswire
(AVTR) Technical Data - news.stocktradersdaily.com
RBC Capital Reaffirms Their Buy Rating on Avantor (AVTR) - The Globe and Mail
Jefferies Maintains a Buy on Avantor (AVTR) With a $20 PT - MSN
Avantor® to Host Second Quarter 2025 Earnings Call on Friday, August 1, 2025 - BioSpace
Avantor to Release Q2 2025 Results on August 1 with Live Webcast - MSN
Avantor's Russell 2500 Inclusion Fuels Institutional Accumulation and Cost-Saving Potential - AInvest
5 Must-Read Analyst Questions From Avantor’s Q1 Earnings Call - Yahoo Finance
Avantor Inc (AVTR) Shares Up 3.23% on Jun 4 - GuruFocus
KeyBanc maintains overweight rating on Avantor stock amid catalysts By Investing.com - Investing.com South Africa
PH Adjuster Memory Market Detailed in New Research Report | Avantor Inc., Thermo Fisher Scientific - openPR.com
KeyBanc maintains overweight rating on Avantor stock amid catalysts - Investing.com
RAYMOND JAMES REITERATES OUTPERFORM RATING FOR AVANTOR STOCK By Investing.com - Investing.com India
Policy Uncertainty Pulled Down Avantor (AVTR) - Insider Monkey
RAYMOND JAMES REITERATES OUTPERFORM RATING FOR AVANTOR STOCK - Investing.com
Long Term Trading Analysis for (AVTR) - news.stocktradersdaily.com
Avantor’s SWOT analysis: stock faces headwinds amid leadership change By Investing.com - Investing.com South Africa
Finanzdaten der Avantor Inc-Aktie (AVTR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.80%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):